Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Effects of Various ATG Doses on Rejection Rate and Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Peter J. Lang, MD, Friedhelm Schuster, Bernd Gruhn, Roland Meisel, MD, Patrick Schlegel, MD, Anne-Marie Lang, Chihab Klose, Wolfgang Schwinger, MD, Tobias F. Feuchtinger, Prof. Dr. MD, Heiko-Manuel Teltschik, Holger Martinius, Michael Schumm, DVM, Rupert Handgretinger, MD

Blood (2017) 130 (Supplement 1): 3250.

https://doi.org/10.1182/blood.V130.Suppl_1.3250.3250

Published: 2017

Journal Articles

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 599.

https://doi.org/10.1182/blood.V130.Suppl_1.599.599

Published: 2017

Journal Articles

Osteonecrosis after Allogeneic HSCT in Children with High-Risk or Relapsed ALL Treated in the ALL-SCT 2003 Trial

Michaela Kuhlen, MD, Michael H. Albert, Peter Bader, MD PhD, Karoline Ehlert, MD, Tayfun Guengoer, Thomas Klingebiel, MD, Peter J. Lang, MD, Martin Schrappe, MD PhD, Johanna Schrum, MD, Ansgar S. Schulz, MD, Arend von Stackelberg, MD, Brigitte Strahm, PD Dr., Karl-Walter Sykora, MD, Irene Teichert-von Luettichau, MD, Arndt Borkhardt, Prof MD, Roland Meisel, MD, Ulrike Poetschger, Evgenia Glogova, Christina Peters, MD

Blood (2017) 130 (Supplement 1): 2004.

https://doi.org/10.1182/blood.V130.Suppl_1.2004.2004

Published: 2017

Journal Articles

Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial

Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD PhD, Sandra Karitzky, PhD, Silke Holtkamp, Christiane Siewert, PhD, Stefanie Pflitsch, Michael Schumm, DVM, Matthias K. Eyrich, MD, Markus Wiesneth, MD, Halvard Bonig, MD MA, Rupert Handgretinger, MD PhD

Blood (2017) 130 (Supplement 1): 214.

https://doi.org/10.1182/blood.V130.Suppl_1.214.214

Published: 2017

Journal Articles

Novel Adapter Chimeric Antigen Receptor (aCAR) T Cells for Temporally Controllable Targeting of Single and Multiple Tumor Antigens

Christian M. Seitz, MD, Patrick Schlegel, MD, Jana Hau, Ann-Christin Krahl, Sarah Schroeder, Giulia Bender, Selina Reiter, Sabine Schleicher, PhD, Karin Schilbach, PhD, Martin Ebinger, MD, Philipp Knopf, MSc, Manfred Kneilling, MD, Bernd J. Pichler, PhD, Joerg Mittelstaet, PhD, Dominik Lock, MSc, Andrew Kaiser, PhD, Peter J. Lang, MD, Rupert Handgretinger, MD

Blood (2017) 130 (Supplement 1): 1912.

https://doi.org/10.1182/blood.V130.Suppl_1.1912.1912

Published: 2017

Journal Articles

Treatment of Patients with Therapy-Refractory Acute GvHD with the Novel MSC Product "MSC-Ffm" Resulted in Excellent Response and Low Mortality: Post-Approval Observational Data from 69 Consecutive Patients

Blood (2017) 130 (Supplement 1): 514.

https://doi.org/10.1182/blood.V130.Suppl_1.514.514

Published: 2017

Journal Articles

TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: First Results of a Prospective Multicenter Phase I/II Clinical Trial

Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD, Sandra Karitzky, PhD, Silke Holtkamp, PhD, Christiane Siewert, PhD, Michael Schumm, VMD, Matthias K. Eyrich, MD, Markus Wiesneth, Halvard Bönig, MD, Rupert Handgretinger, MD

Blood (2016) 128 (22): 389.

https://doi.org/10.1182/blood.V128.22.389.389

Published: 2016

Journal Articles

Decentralized Manufacture of TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Grafts for Children within a Multicenter Phase I/II Clinical Trial

Michael Schumm, VMD, Matthias K. Eyrich, MD, Markus Wiesneth, Halvard Bönig, MD, Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD, Murat Aktas, Philipp Dresing, PhD, Sandra Karitzky, PhD, Silke Holtkamp, PhD, Rupert Handgretinger, MD

Blood (2016) 128 (22): 2172.

https://doi.org/10.1182/blood.V128.22.2172.2172

Published: 2016

Journal Articles

Leukemia Related Co-Stimulation / Co-Inhibition Predict T-Cell Attack of Acute Lymphoblastic Leukemia Mediated By Blinatumomab

Tobias Feuchtinger, MD, Judith Feucht, MD, Simone Kayser, David Gorodezki, Michaela Döring, MD, Franziska Blaeschke, MD, Hans Bösmüller, MD, Leticia Quintanilla-Fend, Prof. Dr., Patrick Schlegel, MD, Martin Ebinger, Peter J. Lang, MD, Rupert Handgretinger, MD

Blood (2015) 126 (23): 3764.

https://doi.org/10.1182/blood.V126.23.3764.3764

Published: 2015

Journal Articles

High Progenitor Cell Frequency at Diagnosis Predicts High Minimal residual Disease Level in Childhood ALL.

Martin Ebinger, Kai Witte, Peter J. Lang, MD, Rupert Handgretinger

Blood (2009) 114 (22): 4705.

https://doi.org/10.1182/blood.V114.22.4705.4705

Published: 2009

Journal Articles

Long Term Survival and Relapse Rate After Transplantation of Highly T and B Cell Depleted Stem Cells From Alternative Donors in Pediatric Patients with Acute Lymphatic Leukemia.

Peter J. Lang, MD, Ingo Mueller, Heiko-Manuel Teltschik, Michael Schumm, Matthias Pfeiffer, Tobias Feuchtinger, Johann Greil, Peter Bader, Thomas Klingebiel, MD, Rupert Handgretinger, MD

Blood (2009) 114 (22): 4333.

https://doi.org/10.1182/blood.V114.22.4333.4333

Published: 2009

Journal Articles

Improved T Cell Recovery After Transplantation of CD3/CD19 depleted Haploidentical Stem Cell Grafts in Pediatric Patients.

Heiko-Manuel Teltschik, Tobias Feuchtinger, Matthias Pfeiffer, Michael Schumm, Ingo Mueller, Rupert Handgretinger, Peter J. Lang, MD

Blood (2009) 114 (22): 4652.

https://doi.org/10.1182/blood.V114.22.4652.4652

Published: 2009

Journal Articles

Germline Mutations in CBL Cause a Predisposition to Juvenile Myelomonocytic Leukemia.

Blood (2009) 114 (22): 310.

https://doi.org/10.1182/blood.V114.22.310.310

Published: 2009

Journal Articles

Co-Transfusion of Donor NK Cells in Haploidentical Stem Cell Transplantation

Peter J. Lang, MD, Matthias Pfeiffer, MD, Heiko-Manuel Teltschik, MD, Ingo Mueller, MD, Tobias Feuchtinger, MD, Michael Schumm, MD, Rupert Handgretinger, MD

Blood (2008) 112 (11): 2907.

https://doi.org/10.1182/blood.V112.11.2907.2907

Published: 2008

Journal Articles

Poor Outcome for Children and Adolescents with Progressive Disease or Relapse of Lymphoblastic Lymphoma - a Report of the BFM Group

Birgit Burkhardt, MD, PhD, Alfred Reiter, MD, Eva Landmann, MD, Peter J. Lang, MD, Lisa Lassay, MD, Roswitha Dickerhoff, MD, Max Lakomek, MD, Guenter Henze, MD, Arend von Stackelberg, MD

Blood (2008) 112 (11): 3589.

https://doi.org/10.1182/blood.V112.11.3589.3589

Published: 2008

Journal Articles

Low Transplant Related Toxicity and Mortality after Transplantation of CD3/CD19 Depleted Haploidentical Stem Cells with Reduced Intensity Conditioning in Children.

Peter J. Lang, MD, Ingo Mueller, MD, Heiko Teltschik, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Michael Schumm, MD, Rupert Handgretinger, MD

Blood (2007) 110 (11): 3076.

https://doi.org/10.1182/blood.V110.11.3076.3076

Published: 2007

Journal Articles

A New Conditioning Regimen with Clofarabine for Allogeneic Stem Cell Transplantation in Pediatric Patients with Refractory Disease.

Peter J. Lang, MD, Ingo Mueller, MD, Heiko Teltschik, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Tobias Feuchtinger, MD, Rupert Handgretinger, MD

Blood (2007) 110 (11): 3019.

https://doi.org/10.1182/blood.V110.11.3019.3019

Published: 2007

Journal Articles

Quantitative HLA Class I Expression and KIR-Mismatch between NK-Cell-Donor and Patient Predict NK Cell Mediated Lysis of Leukemic Cells from Children with Acute Lymphatic Leukemia.

Matthias M. Pfeiffer, MD, Michael Schumm, Klaus Dietz, Tobias Feuchtinger, MD, Rupert Handgretinger, MD, Peter J. Lang, MD

Blood (2006) 108 (11): 5205.

https://doi.org/10.1182/blood.V108.11.5205.5205

Published: 2006

Journal Articles

Retransplantation with Stem Cells from Mismatched Related Donors after Graft Rejection in Pediatric Patients.

Peter J. Lang, MD, Johann Greil, MD, Ingo Müller, MD, Peter Bader, MD, Thomas Klingebiel, MD, Frank Heinzelmann, MD, Claus Belka, MD, Bernhard Kremens, MD, Alfred Reiter, MD, Paul G. Schlegel, MD, Rupert Handgretinger, MD

Blood (2006) 108 (11): 2955.

https://doi.org/10.1182/blood.V108.11.2955.2955

Published: 2006

Journal Articles

CD3/CD19 Depleted Grafts for Haploidentical Stem Cell Transplantation in Children: Results of a Pilot Study.

Peter J. Lang, MD, Ingo Mueller, MD, Johann Greill, MD, Peter Bader, MD, Michael Schumm, Dr. med. vet., Matthias Pfeiffer, MD, Tobias Feuchtinger, MD, Rupert Handgretinger, MD

Blood (2006) 108 (11): 3121.

https://doi.org/10.1182/blood.V108.11.3121.3121

Published: 2006

NARROW

Effects of Various ATG Doses on Rejection Rate and Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

Osteonecrosis after Allogeneic HSCT in Children with High-Risk or Relapsed ALL Treated in the ALL-SCT 2003 Trial

Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial

Novel Adapter Chimeric Antigen Receptor (aCAR) T Cells for Temporally Controllable Targeting of Single and Multiple Tumor Antigens

Treatment of Patients with Therapy-Refractory Acute GvHD with the Novel MSC Product "MSC-Ffm" Resulted in Excellent Response and Low Mortality: Post-Approval Observational Data from 69 Consecutive Patients

TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: First Results of a Prospective Multicenter Phase I/II Clinical Trial

Decentralized Manufacture of TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Grafts for Children within a Multicenter Phase I/II Clinical Trial

Leukemia Related Co-Stimulation / Co-Inhibition Predict T-Cell Attack of Acute Lymphoblastic Leukemia Mediated By Blinatumomab

High Progenitor Cell Frequency at Diagnosis Predicts High Minimal residual Disease Level in Childhood ALL.

Long Term Survival and Relapse Rate After Transplantation of Highly T and B Cell Depleted Stem Cells From Alternative Donors in Pediatric Patients with Acute Lymphatic Leukemia.

Improved T Cell Recovery After Transplantation of CD3/CD19 depleted Haploidentical Stem Cell Grafts in Pediatric Patients.

Germline Mutations in CBL Cause a Predisposition to Juvenile Myelomonocytic Leukemia.

Co-Transfusion of Donor NK Cells in Haploidentical Stem Cell Transplantation

Poor Outcome for Children and Adolescents with Progressive Disease or Relapse of Lymphoblastic Lymphoma - a Report of the BFM Group

Low Transplant Related Toxicity and Mortality after Transplantation of CD3/CD19 Depleted Haploidentical Stem Cells with Reduced Intensity Conditioning in Children.

A New Conditioning Regimen with Clofarabine for Allogeneic Stem Cell Transplantation in Pediatric Patients with Refractory Disease.

Quantitative HLA Class I Expression and KIR-Mismatch between NK-Cell-Donor and Patient Predict NK Cell Mediated Lysis of Leukemic Cells from Children with Acute Lymphatic Leukemia.

Retransplantation with Stem Cells from Mismatched Related Donors after Graft Rejection in Pediatric Patients.

CD3/CD19 Depleted Grafts for Haploidentical Stem Cell Transplantation in Children: Results of a Pilot Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only